Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis (Q35636708)
Jump to navigation
Jump to search
scientific article published on 13 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis |
scientific article published on 13 July 2005 |
Statements
1 reference
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis (English)
1 reference
D van der Heijde
1 reference
A Boonen
1 reference
J L Severens
1 reference
A Boendermaker
1 reference
R Landewé
1 reference
J Braun
1 reference
J Brandt
1 reference
J Sieper
1 reference
Sj van der Linden
1 reference
13 July 2005
1 reference
1 reference
65
1 reference
2
1 reference
201-208
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference